Top Clinical Trials companies in Singapore by Return on Assets (ROA)

This ranking features the top 2 Clinical Trials companies in Singapore ranked by Return on Assets (ROA), averaging a Return on Assets (ROA) of -12.77%, for February 08, 2025.

Singapore

Clinical Trials
Return on Assets (ROA)
#
Name
Return on Assets (ROA)
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
950210.KS

Prestige BioPharma Limited

1

950210.KS
-4.63%
June 30, 2024 USD 10.41 0.13%

Singapore
2
WVE

Wave Life Sciences Ltd.

2

WVE
-20.92%
Dec. 31, 2023 USD 11.57 -4.06%

Singapore
Frequently Asked Questions
  • Which Clinical Trials company in Singapore has the highest Return on Assets (ROA) ?

    The Clinical Trials company in Singapore with the highest Return on Assets (ROA) is Prestige BioPharma Limited (KSE: 950210.KS) at -4.63%.

  • Which Clinical Trials company in Singapore has the lowest Return on Assets (ROA) ?

    The Clinical Trials company in Singapore with the lowest Return on Assets (ROA) is Wave Life Sciences Ltd. (NasdaqGM: WVE) at -20.92%.

SV Wall Street